Analysis of Voluntary Behavior to Interrogate Neural Function

Mice and rats are critical to our understanding of human biology. They share most of our genome, are susceptible to most of the same diseases and usually benefit from clinical therapeutics, if only at very high doses. Equally important has been the development of new rodent research tools that allow us to manipulate their genome, to induce new likenesses and illuminate our similarities. However, there remain substantial obstacles to modeling clinically relevant human somatosensory experiences, such as chronic pain, in rodents. Conventional rodent pain assays require robust stimuli to generate brief behavioral readouts and they are able to detect the effects of analgesics only at levels well beyond clinically effective human doses. New technologies are needed that are sensitive to low intensity nociceptive stimuli and are able to detect the effects of analgesic drugs at clinically relevant doses. It is possible to tell when someone is in pain simply by his or her body language; but rodents and other prey animals do not as readily show behaviors that betray the presence of pain or injury. We propose that ancestral selection pressures have favored propagation of prey that mask outward signs of injury or disease from the predator, and that behavioral indicators of ongoing pain or itch in rodents should therefore be most evident when the appearance of predation risk is minimized and/or from a viewpoint not naturally seen by predators. Based on this hypothesis, we developed new devices and techniques for observation and analysis of voluntary rodent behavior, with careful consideration of their ecological position as nocturnal prey animals. Here, we demonstrate the capability of one of these new technologies to detect the prolonged effects of low intensity nociceptive stimuli in freely behaving mice and rats and to

[1]  David P. Roberson,et al.  Targeting of sodium channel blockers into nociceptors to produce long‐duration analgesia: a systematic study and review , 2011, British journal of pharmacology.

[2]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[3]  David P. Roberson,et al.  Coapplication of Lidocaine and the Permanently Charged Sodium Channel Blocker QX-314 Produces a Long-lasting Nociceptive Blockade in Rodents , 2009, Anesthesiology.

[4]  Xinzhong Dong,et al.  The Distinct Roles of Two GPCRs, MrgprC11 and PAR2, in Itch and Hyperalgesia , 2011, Science Signaling.

[5]  Youngnam Kang,et al.  Selectively targeting pain in the trigeminal system , 2010, PAIN.

[6]  Ling Wei,et al.  Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α , 2012, Neurobiology of Disease.

[7]  R. LaMotte,et al.  Behavioral differentiation between itch and pain in mouse , 2008, PAIN.

[8]  Barbara Namer,et al.  Separate peripheral pathways for pruritus in man. , 2008, Journal of neurophysiology.

[9]  E. Carstens,et al.  Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch , 2010, PAIN®.

[10]  Román A. Corfas,et al.  Loss of Inhibitory Interneurons in the Dorsal Spinal Cord and Elevated Itch in Bhlhb5 Mutant Mice , 2010, Neuron.

[11]  H. Handwerker,et al.  Conditioning of histamine by bradykinin alters responses of rat nociceptor and human itch sensation , 1993, Neuroscience Letters.

[12]  E. Carstens,et al.  Facial injections of pruritogens and algogens excite partly overlapping populations of primary and second-order trigeminal neurons in mice. , 2010, Journal of neurophysiology.

[13]  E. Carstens,et al.  Enhanced responses of lumbar superficial dorsal horn neurons to intradermal PAR-2 agonist but not histamine in a mouse hindpaw dry skin itch model. , 2011, Journal of neurophysiology.

[14]  B. Davis,et al.  Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity , 2007, Nature Protocols.

[15]  Alexandru D. P. Papoiu,et al.  What causes itch in atopic dermatitis? , 2008, Current allergy and asthma reports.

[16]  David J. Anderson,et al.  Sensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus , 2009, Cell.

[17]  Yiyuan Cui,et al.  A subpopulation of nociceptors specifically linked to itch , 2012, Nature Neuroscience.

[18]  Robert H. LaMotte,et al.  Similar itch and nociceptive sensations evoked by punctate cutaneous application of capsaicin, histamine and cowhage , 2009, PAIN®.

[19]  B. Namer,et al.  Scratching an itch , 2013, Nature Neuroscience.

[20]  R. Gereau,et al.  A Novel Behavioral Assay for Measuring Cold Sensation in Mice , 2012, PloS one.

[21]  David J. Anderson,et al.  TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms , 2009, Proceedings of the National Academy of Sciences.

[22]  R. Ji,et al.  Oxidative stress induces itch via activation of transient receptor potential subtype ankyrin 1 in mice , 2012, Neuroscience Bulletin.

[23]  M. Simon,et al.  Phospholipase Cβ 3 Mediates the Scratching Response Activated by the Histamine H1 Receptor on C-Fiber Nociceptive Neurons , 2006, Neuron.

[24]  Misook Kim,et al.  TRPV1 Mediates Histamine-Induced Itching via the Activation of Phospholipase A2 and 12-Lipoxygenase , 2007, The Journal of Neuroscience.

[25]  E. Carstens,et al.  Differential itch- and pain-related behavioral responses and µ-opoid modulation in mice. , 2010, Acta dermato-venereologica.

[26]  P. Reeh,et al.  The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. , 2008, The Journal of clinical investigation.

[27]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[28]  N. Hirasawa,et al.  The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti‐pruritic and anti‐inflammatory effects in NC/Nga mice , 2012, Allergy.

[29]  Xinzhong Dong,et al.  TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch , 2011, Nature Neuroscience.

[30]  B. Bean,et al.  Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314. , 2013, Journal of neurophysiology.

[31]  Yang Liu,et al.  VGLUT2-Dependent Glutamate Release from Nociceptors Is Required to Sense Pain and Suppress Itch , 2010, Neuron.

[32]  R. LaMotte,et al.  Mechanisms of Itch Evoked by β-Alanine , 2012, The Journal of Neuroscience.

[33]  Donghee Kim,et al.  Pore dilation occurs in TRPA1 but not in TRPM8 channels , 2009, Molecular pain.

[34]  Zhou-Feng Chen,et al.  Cellular Basis of Itch Sensation , 2009, Science.

[35]  Xinzhong Dong,et al.  Agonists of the Mas-Related Gene (Mrgs) Orphan Receptors as Novel Mediators of Mast Cell-Sensory Nerve Interactions1 , 2008, The Journal of Immunology.

[36]  M. Nagamine,et al.  Cross-sensitization of histamine-independent itch in mouse primary sensory neurons , 2012, Neuroscience.

[37]  Clifford J. Woolf,et al.  Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers , 2007, Nature.

[38]  Hong Liang Tey,et al.  Cowhage-Induced Itch as an Experimental Model for Pruritus. A Comparative Study with Histamine-Induced Itch , 2011, PloS one.

[39]  METHODOLOGICAL ASPECTS , 1976 .

[40]  Yan-Gang Sun,et al.  A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord , 2007, Nature.

[41]  H O Handwerker,et al.  Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. , 2003, Journal of neurophysiology.

[42]  David P. Roberson,et al.  Phenotyping the Function of TRPV1-Expressing Sensory Neurons by Targeted Axonal Silencing , 2013, The Journal of Neuroscience.

[43]  D. Klumpp,et al.  Mast Cell-Derived Histamine Mediates Cystitis Pain , 2008, PloS one.

[44]  I. Bygbjerg,et al.  Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations , 2011, Malaria Journal.